UCB Biopharma
May 25, 2020
R&D and Upcoming therapies Paving the Way for a Potential and Better Cure for Immune Thrombocytopenia
The Immune Thrombocytopenia market size in the 7MM was estimated to be approximately USD 2,527.72 million in 2017. The US accounts for the largest ITP Market size. A disorder that results in an isolated low platelet count, Immune thrombocytopenia (ITP), is an autoimmune disorder that results in convincing body...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
